Zenas BioPharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 20 Sep 24 | BuyUS$360,820 | Tellus BioVentures, LLC | Company | 20,000 | US$18.97 | |
| 16 Sep 24 | BuyUS$7,480,000 | Longitude Capital Management Co., LLC | Company | 440,000 | US$17.00 | |
| 16 Sep 24 | BuyUS$15,000,001 | Zebra Aggregator, LP | Company | 882,353 | US$17.00 | |
| 16 Sep 24 | BuyUS$37,999,998 | SR One Capital Management, LP | Company | 2,235,294 | US$17.00 | |
| 16 Sep 24 | BuyUS$5,100,000 | Fairmount Funds Management LLC | Company | 300,000 | US$17.00 | |
| 16 Sep 24 | BuyUS$7,480,000 | Longitude Capital Management Co., LLC | Company | 440,000 | US$17.00 | |
| 13 Sep 24 | BuyUS$999,991 | Hongbo Lu | Individual | 58,823 | US$17.00 |
Insider Trading Volume
Insider Buying: ZBIO insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 251,736 | 0.603% |
| Public Companies | 4,513,161 | 10.8% |
| Institutions | 9,566,310 | 22.9% |
| VC/PE Firms | 10,027,421 | 24% |
| General Public | 17,419,047 | 41.7% |
Dilution of Shares: ZBIO only recently listed within the past 12 months
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 4,911,539 | US$95.7m | 83.5% | 16.74% | |||
| 3,761,359 | US$73.3m | 30.7% | no data | |||
| 3,098,380 | US$60.4m | 0% | no data | |||
| 2,613,948 | US$50.9m | 81.7% | 2.7% | |||
| 2,501,934 | US$48.8m | 21.3% | 9.13% | |||
| 1,892,806 | US$36.9m | 18.8% | 2.59% | |||
| 1,672,039 | US$32.6m | 1.21% | no data | |||
| 1,438,482 | US$28.0m | 0% | 8.21% | |||
| 1,414,781 | US$27.6m | 0% | no data | |||
| 801,624 | US$15.6m | 0% | no data | |||
| 161,155 | US$3.1m | 0% | no data | |||
| 58,823 | US$1.1m | 0% | no data | |||
| 31,758 | US$619.0k | 0% | no data |